cenx posts
FeedPosted Jan 21st 2009 11:57AM by Eric Buscemi (RSS feed)
Filed under: Analyst reports, Analyst upgrades and downgrades, Google (GOOG), Wal-Mart (WMT), Ford Motor (F), McDonald's (MCD), Alcoa Inc (AA), QUALCOMM Inc (QCOM), Burger King Hldgs (BKC), Harley-Davidson (HOG), Analyst initiations, Freep't McMoRan Copper (FCX)
Analyst upgrades:
- Goldman added McDonald's (NYSE:MCD) to its Conviction Buy List as they believe the company will beat their earnings expectations over the next couple quarters. Note that Burger King (NYSE:BKC) was removed from the list.
- Baird upgraded Woodward Govenor (NASDAQ:WGOV) to Outperform from Neutral citing increased confident in its outlook following the better-than-expected Q1 report.
- Citigroup upgraded Harley-Davidson (NYSE:HOG) to Hold from Sell and removed shares from their Top Picks Live List as a Sell as they believe current expectations are very low following the recent weakness. Citigroup lowered their target price to $13 from $18.
- Ford (NYSE:F) and Lear (NYSE:LEA) were upgraded to Hold from Sell at Deutsche Bank.
- KT Corp (NYSE:KTC) was raised to Overweight from Neutral at HSBC.
- Ryanair (NASDAQ:RYAAY) was upgraded to Hold from Sell at Collins Stewart and to Buy from Neutral at UBS.
Analyst downgrades:
- Goldman removed Burger King (NYSE:BKC) from its Conviction Buy List citing recent share strength. Note that McDonald's (NYSE:MCD) was added to the list.
- Keefe Bruyette downgraded shares of Och-Ziff Capital (NYSE:OZM) to Market Perform from Outperform to reflect the company's near-term headwinds. The firm lowered their target to $5 from $6.50.
- Morgan Stanley downgraded Freeport-McMoRan (NYSE:FCX), Alcoa (NYSE:AA), and Century Aluminum (NASDAQ:CENX) to Equal Weight from Overweight as they believe industrial metals will be depressed through next year.
- Air France (Other OTC:AFLYY) was downgraded to Sell from Neutral at UBS.
- Wal-Mart (NYSE:WMT) was lowered to Neutral from Outperform at Credit Suisse.
- Radware (NASDAQ:RDWR) was cut at Argus to Hold from Buy.
Analyst initiations:
- Merriman initiated Suntech (NYSE:STP) with a Sell rating. The firm is concerned by the company's debt load and narrowing maturity and thinks further cost reduction in China could be a challenge. The firm believes a fair price target range is $3.50-$4.50 per share.
- JMP Securities views Google (NASDAQ:GOOG) as a long-term "must buy" given its dominant market position, strong balance sheet, and low valuation. Shares were initiated with an Outperform rating and $400 target.
- Auriga started Micron (NYSE:MU) with a Buy rating and $5 target. The firm expects DRAM oversupply to ease in the second half of 2009 and believes Micron will not burn significant cash this year.
- Qualcomm (NASDAQ:QCOM) was initiated at Morgan Stanley with an Equal Weight rating and $41 target.
- Core Laboratories (NYSE:CLB) was initiated with a Buy rating and $80 target at Wunderlich.
- Mylan (NASDAQ:MYL) was started with a Buy rating and $16 target at Citigroup.
Posted Jul 22nd 2008 12:12PM by Eric Buscemi (RSS feed)
Filed under: Alcoa Inc (AA), , Allegheny Technologies (ATI), Analyst initiations, salesforce.com inc (CRM)
MOST NOTEWORTHY: The Metals and Mining sector, Lamar Advertising and Rigel Pharmaceuticals were today's noteworthy initiations:
- Banc of America initiated the Metals and Mining sector with an Equal Weight rating and believes investors should take a selective approach to stocks in the group. The firm initiated Alcoa (NYSE: AA) and RTI International Metals (NYSE: RTI) with Buy ratings and a $44 target and $41 target, and started Allegheny Tech (NYSE: ATI), Century Aluminum (NASDAQ: CENX) and Titanium Metals (NYSE: TIE) with Neutral ratings and a $64 target, $58 target and $12 target, respectively.
- Lamar Advertising (NASDAQ: LAMR) was initiated at Caris with an Above Average rating and $40 target. Caris is positive on the company's North American focus and exposure to the aggressive deployment of digital boards.
- Stanford believes Rigel Pharma's (NASDAQ: RIGL) lead drug R788 has the potential to be the first oral drug for rheumatoid arthritis and expects clinical news flow and partnerships to serve as catalysts. Shares were initiated with a Buy rating and $30 target.
OTHER INITIATIONS:
- Thomas Weisel assumed Salesforce.com (NYSE: CRM) with an Overweight rating and $90 target.
- International Flavors (NYSE: IFF) was initiated at Lehman with an Underweight rating.
- JP Morgan started Ares Capital (NASDAQ: ARCC) with an Underweight rating.